May 20-21, 2016 - Mayo Clinic Hospital, St. Mary's Campus, Rochester MN 
Course Directors: Ralitza Gavrilova, M.D. and Marc Patterson, M.D.

The goals of this course are to define mitochondrial disorders and the basic evaluation, discuss the level of certainty that the diagnosis of mitochondrial disease is correct, introduce the concepts of primary and secondary mitochondrial disorders, and discuss the particular subject of dysautonomia in the context of mitochondrial disease.  The speakers at this course are outstanding teachers and  leaders in the field of mitochondrial medicine.  

The second day of the course is designed for patients and family members.

For more information and to register online.

Location
Mayo Clinic Hospital – Saint Marys Campus
Joseph Building, Room MN-59
1216 Second Street SW
Rochester, MN  55902

AMA Credit: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Mayo Clinic College of Medicine and the United Mitochondrial Disease Foundation. Mayo Clinic College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.  This live activity has been approved for a maximum of 6.25 PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Target Audience
This course is designed for:  MD's, Residents, Fellows, Students, APNs,  PAs, RNs, Pharmacists and Genetic Counselors in mitochondrial medicine.

Learning Objectives

Upon conclusion of this program, participants should be able to:

  • Describe the basic science of mitochondrial physiology and genetics
  • Summarize the role of ATP flux and Redox dysfunction as it pertains to mitochondrial disease
  • List the symptoms of mitochondrial disease
  • Recognize the red-flag symptoms
  • Demonstrate how to begin a diagnostic mitochondrial evaluation
  • Describe the issues surrounding the certainty, or lack of certainty of a firm diagnosis
  • Identify the concepts of primary and secondary mitochondrial disorders
  • Summarize the goals of therapy and present the current treatments available based on the most recent studies presented in the peer-reviewed medical literature
  • Describe available diagnostic testing, based on mitochondrial function, and to review new and expanding opportunities including next gen sequencing
  • Summarize a current clinical trial investigating potential new therapies for Friedreich's Ataxia
  • Describe treatment and management approaches to lactic acidosis

Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.